Yusuke Kawamura

Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

Tetsuya Hosaka, Fumitaka Suzuki, Masahiro Kobayashi et al. · Hepatology · 2012 · 709 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Shukui Qin, Minshan Chen, Ann‐Lii Cheng et al. · The Lancet · 2023 · 488 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Large-Scale Long-Term Follow-Up Study of Japanese Patients With Non-Alcoholic Fatty Liver Disease for the Onset of Hepatocellular Carcinoma

Yusuke Kawamura, Yasuji Arase, Kenji Ikeda et al. · The American Journal of Gastroenterology · 2011 · 279 citations

Medicine, Oncology, Cancer Epidemiology +16

Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: Amino acid substitutions in the core region and low-density lipoprotein cholesterol levels

Norio Akuta, Fumitaka Suzuki, Yusuke Kawamura et al. · Journal of Hepatology · 2006 · 266 citations

Pharmacy, Infectious Diseases, Pharmacology +17

Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C†

Yasuji Arase, Fumitaka Suzuki, Yoshiyuki Suzuki et al. · Hepatology · 2008 · 263 citations

Medicine, Infectious Diseases, Internal Medicine +17